← Leaderboards
Larry Ereshefsky
University Of Texas Hlth Sci Ctr San Ant
$760,315
Attributed
$760,315
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$760,315 · 3
By mechanism
M01$760,315 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Sci Ctr San Ant
Same institution · by research overlap
- Alan Frazer$9,968,319
- Lynette C Daws$13,518,910
- John D Roache$2,392,034
- Julie Gorton Hensler$2,815,647
- Richard J Lamb$6,722,506
Others in their field
Top investigators on “Human Therapy Evaluation”
- Lawrence Corey · Fred Hutchinson Cancer Center$368,153,539
- David Heimbrook · Leidos Biomedical Research, Inc.$241,598,366
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barbara Driver · Westat, Inc.$206,347,735
- Carol Nesel · Westat$188,148,170
- Constance Ann Benson · University Of California, San Diego$179,950,251
Research focus
Human Therapy EvaluationHuman SubjectClinical ResearchPharmacokineticsSerotonin InhibitorDrug InteractionsDrug Screening /EvaluationMental Disorder ChemotherapyAbnormal Involuntary MovementAlprazolamAntidepressantsAntipsychotic AgentsClozapineDrug Adverse EffectNeuropsychological TestsEnzyme InhibitorsEnzyme ActivityCytochrome OxidaseUrinalysisParoxetineCitalopramBlood ChemistryFluoxetine
Grant awards (9)
Drug Interaction Evaluation of Citalopram, Paroxetine$39,395
M01 · FY2004 · RR
EFFECTS OF REBOXETINE &NEFAZODONE ON PHARMACOKINETICS OF ALPRAZOLAM$234,837
M01 · FY2002 · RR
EFFECTS OF REBOXETINE &NEFAZODONE ON PHARMACOKINETICS OF ALPRAZOLAM$234,837
M01 · FY2002 · RR
PHARMACOKINETICS OF GENERIC CLOZAPINE VS CLOZARIL$0
M01 · FY2002 · RR
PHARMACOKINETICS OF GENERIC CLOZAPINE VS CLOZARIL$0
M01 · FY2002 · RR
EFFECTS OF REBOXETINE &NEFAZODONE ON PHARMACOKINETICS OF ALPRAZOLAM$234,837
M01 · FY2001 · RR
PHARMACOKINETICS OF GENERIC CLOZAPINE VS CLOZARIL$0
M01 · FY2001 · RR
EFFECTS OF REBOXETINE &NEFAZODONE ON PHARMACOKINETICS OF ALPRAZOLAM$16,409
M01 · FY2000 · RR
PHARMACOKINETICS OF GENERIC CLOZAPINE VS CLOZARIL$0
M01 · FY2000 · RR